4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression (Homo sapiens)
From WikiPathways
Description
This pathway is modeled after Figure 7 in the article Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids (See Bibliography).
Quality Tags
Ontology Terms
Bibliography
- Eto I; ''Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.''; Cancer Cell Int, 2010 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
4-Hydroxytamoxifen | Metabolite | 449459 (PubChem-compound) | |
4E-BP1 | GeneProduct | Q13541 (Ensembl) | |
Cap-Independent Translation Initiation of p27 mRNA Through its 5'UTR | Pathway | Identifier not found | |
Dexamethasone | Metabolite | 5743 (PubChem-compound) | |
ERK Inhibitor I | Metabolite | 16218944 (PubChem-compound) | |
ERK1 | GeneProduct | ENSG00000102882 (Ensembl) | |
ERK2 | GeneProduct | ENSG00000100030 (Ensembl) | |
MEK1 | GeneProduct | ENSG00000169032 (Ensembl) | |
MEK2 | GeneProduct | ENSG00000126934 (Ensembl) | |
MKK3 | GeneProduct | ENSG00000034152 (Ensembl) | |
MKK6 | GeneProduct | ENSG00000108984 (Ensembl) | |
MNK1 | GeneProduct | ENSG00000079277 (Ensembl) | |
MNK2 | GeneProduct | ENSG00000099875 (Ensembl) | |
MTOR Protein Kinase Signaling Pathway | Pathway | WP3318 (WikiPathways) | |
Mlk3 | GeneProduct | ENSG00000173327 (Ensembl) | |
NSC119889 | Metabolite | 274104 (PubChem-compound) | |
PD98059 | Metabolite | 4713 (PubChem-compound) | |
Raf | GeneProduct | ENSG00000132155 (Ensembl) | |
Retinoic Acids? | Metabolite | HMDB01852 (HMDB) | |
SB202190 | Metabolite | 5353940 (PubChem-compound) | |
eIF4E | GeneProduct | ENSG00000151247 (Ensembl) | |
p38MAPK | GeneProduct | ENSG00000197442 (Ensembl) |
Annotated Interactions
No annotated interactions